Plasmacytoma Clinical Trials in Shenzhen, Guangdong
2 recruitingShenzhen, Guangdong, China
Showing 1–2 of 2 trials
Recruiting
Phase 1
Engineered Dendritic Cell Vaccines for Multiple Myeloma
Multiple Myeloma or Plasmacytoma
Shenzhen Geno-Immune Medical Institute10 enrolled2 locationsNCT06435910
Recruiting
Phase 1Phase 2
Frontline Combination CAR-T Cell Therapy for Multiple Myeloma or Plasmacytoma
Multiple MyelomaPlasmacytoma
Shenzhen Geno-Immune Medical Institute20 enrolled2 locationsNCT06429150